Welcome to our dedicated page for Datavault AI news (Ticker: DVLT), a resource for investors and traders seeking the latest updates and insights on Datavault AI stock.
Datavault AI Inc. provides data monetization, credentialing, digital engagement and real-world asset tokenization technologies through a cloud-based platform spanning Acoustic Sciences and Data Sciences. Its recurring announcements describe AI-driven data experiences, asset valuation and monetization, Information Data Exchange® capabilities for Digital Twins and name, image and likeness licensing, and patented audio technologies including WiSA, ADIO and Sumerian.
Company news also covers registered equity offerings, use of proceeds for a quantum-ready GPU edge network, financial-results communications, and material agreements tied to tokenized assets and exchange technology. Updates often connect Datavault AI's common stock capital structure with product deployment, licensing, analytics, marketing automation and industry applications in sports and entertainment, education, fintech, healthcare, energy and other markets.
Datavault AI (NASDAQ:DVLT) announced that the WiSA Association, part of its Acoustic Sciences division, has granted WiSA SoundSend Certification to Optoma's HCPro-5400 and UHZ58LV 4K UHD laser projectors and 66 additional related models. The certification confirms seamless connectivity with both the existing WiSA SoundSend universal wireless audio transmitter and the forthcoming WiSA SoundSend E, enabling wireless, high-fidelity audio with WiSA Certified speakers.
The SoundSend E will be managed through the new WiSA Connect mobile app, designed for system control, tuning, and management of WiSA E systems in the home. According to Datavault AI, this supports broader adoption of its WiSA ecosystem across home theater applications.
Datavault AI (Nasdaq: DVLT) signed a definitive agreement to acquire BankWyse, a Cheyenne, Wyoming Special Purpose Depository Institution, subject to regulatory approval and customary closing conditions. According to Datavault AI, the deal is intended to add the final component to its end-to-end data monetization ecosystem.
BankWyse holds a Wyoming SPDI bank charter, integrating qualified digital-asset custody with a commercial banking platform for interoperability between digital assets and fiat currencies. As a fully-reserved depository institution, its fiat deposits are not required to be insured by the FDIC. Datavault AI plans to combine data valuation, tokenization, custody, exchange trading and banking services so customers can tokenize and trade real-world assets within a single AI-driven platform.
Datavault AI (Nasdaq: DVLT) has closed its acquisition of NYIAX, a contract management exchange operating one of the first blockchain-enabled marketplaces for trading guaranteed contractual assets. The deal adds institutional-grade exchange technology, blockchain settlement infrastructure and a portfolio of jointly owned patents to Datavault AI’s digital and real-world asset tokenization platform.
NYIAX contributes an asset-agnostic exchange stack, four issued U.S. patents covering electronic continuous trading of variant inventories, and the commercialization capabilities of Collective Audience. According to Datavault AI, the combined platform now spans data origination, AI-driven valuation, tokenization, exchange infrastructure, commercialization and compliance, supporting specialized exchanges across emerging asset categories. NYIAX is expected to recommend two board candidates as integration advances.
Datavault AI (NASDAQ: DVLT) reported Q2 2026 revenue of $6.7 million, up 287% from $1.7 million in Q2 2025, with gross profit rising to $2.9 million from $35,000. The company reiterated its full-year 2026 revenue target of at least $200 million, implying roughly 400% year-over-year growth.
Q2 operating expenses rose to $29.3 million, driving a loss from operations of $26.5 million and a net loss attributable to common stockholders of $88.0 million. Datavault AI completed the NYIAX acquisition, signed a definitive agreement to acquire CyberCatch, expanded its SanQtum edge AI infrastructure and announced plans to tokenize Available Infrastructure’s Project Qestrel. Cash stood at $1.4 million, crypto assets at $49.0 million and stockholders’ equity at $245.9 million as of June 30, 2026.
DataMeds AI (NASDAQ:MEDS)/b) reported Q2 2026 net revenues of
The company raised $6.5 million in June 2026, restructured $14.5 million of debt and ended June with $2.46 million in cash but a stockholders’ deficit of $19.50 million. Corporate actions included a 1‑for‑50 reverse split, a July 2026 rebrand from Wellgistics Health to DataMeds AI with ticker change to MEDS, and lock‑up agreements covering about 49% of outstanding shares.
Strategically, DataMeds AI agreed to the pending “Datavault Transaction” with Datavault AI (NASDAQ:DVLT), EOS Technology Holdings and Scilex Holdings to expand its PharmacyChain license, acquire QOLPOM biometric patents and a controlling interest in Tollo Health. It plans to launch the Health Lives Here app with NFL Alumni Health in September 2026 targeting GLP‑1 patients in rural communities, supported by Corexa Health and new products such as Forzet, Tollovid and Galectovid.
Datavault AI (NASDAQ: DVLT) signed a definitive agreement to acquire 100% of CyberCatch Holdings (TSXV: CYBE, OTCQB: CYBHF) in an all-cash transaction structured as a court-approved plan of arrangement in British Columbia. Datavault AI will purchase approximately 26.8 million CyberCatch common shares for total cash consideration of USD $94.5 million, or USD $3.53 per share, with all dilutive securities exchanged on a cashless basis.
Subject to CyberCatch shareholder, court, TSX Venture Exchange and customary approvals, CyberCatch will become a wholly owned subsidiary based in San Diego, led by founder Sai Huda as President reporting to Datavault AI CEO Nathaniel T. Bradley. CyberCatch’s AI-enabled continuous compliance and cyber risk mitigation platform, including its MARS-MABE quantum-resistant encryption technology, is expected to become the cybersecurity and compliance layer across Datavault AI’s Quantum Private Network and broader data and acoustic technology stack.
Datavault AI (NASDAQ:DVLT) has appointed intellectual property market pioneer Dean Becker as Chief Licensing Officer, effective immediately. He will lead licensing, valuation, monetization, and enforcement strategy for the company’s global IP portfolio across its Data Science and Acoustic Science divisions.
Becker is described as a veteran patent dealmaker with more than $11 billion in completed IP-based transactions over a 30+ year career. He previously created the Ocean Tomo patent auction business, later sold to ICAP, and led several ICAP IP units, overseeing record-setting patent transactions in sectors including cloud computing, social networking, smart cards, and consumer electronics.
At Datavault AI, Becker’s mandate covers assets such as the Information Data Exchange® (IDE), DataScore®, DataValue®, RWA tokenization technologies, and the company’s WiSA®, ADIO®, and Sumerian® audio IP. According to the company, the move underscores its identity as a technology licensing business focused on monetizing foundational data and acoustic patents.
DataMeds AI (NASDAQ:MEDS) reported it has completed the renaming of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy and Corexa Tech & Hub, under a newly renamed pharmacy-focused division, Corexa Health. The company’s pharmaceutical distribution subsidiary will remain Wellgistics.
According to DataMeds AI, the new Corexa Health structure is intended to separate pharmacy operations from other planned healthcare services divisions in telemedicine and diagnostic laboratories. The company also plans to expand its EinsteinRx AI platform using intellectual property licensed from DataVault AI (NASDAQ:DVLT), alongside proposed acquisitions of Tollo Health and QOLPOM-related intellectual property to support rural-focused, direct-to-consumer healthcare services.
Datavault AI (NASDAQ: DVLT) will release its second quarter 2026 financial results before the market opens on Wednesday, August 19, 2026. The company will host a conference call and live webcast the same day at 8:30 a.m. ET, featuring CEO Nathaniel Bradley and CFO Brett Moyer, with a replay available later on its investor website.
DataMeds AI (NASDAQ:MEDS) and Datavault AI (NASDAQ:DVLT) amended their definitive agreement to expand the PharmacyChain blockchain-related technology license from pharmaceutical distribution into all unencumbered commercial healthcare, healthspan and wellness uses of Datavault AI intellectual property. The amendment, completed ahead of a proposed multi-party business combination involving Scilex Holdings, EOS Technology Holdings’ QOLPOM patent portfolio and the acquisition of a controlling interest in Tollo Health, is intended to support the private launch of the Health Lives Here app to NFL Alumni Health members on August 6, 2026. Under the revised terms, Datavault AI will receive common shares equal to about 19.9% of DataMEDS common stock, instead of preferred shares, upon satisfaction of closing conditions, with the share value expected to be recognized as revenue by Datavault AI. DataMEDS also highlighted its recent Nasdaq listing under “MEDS” and a planned dividend of 50 Dream Bowl Meme Coin tokens per share as of an August 7, 2026 record date, subject to change at its discretion.